NeuPath Health at Planet MicroCap Showcase: Toronto 2026: growth plan

On October 28, 2026, NeuPath Health (NPTH) presented its growth strategy at the Planet MicroCap Showcase: Toronto 2026. The company highlighted its steady revenue growth and cash flow positivity, despite a shortage of doctors and long patient wait times. NeuPath operates 13 clinics, primarily in Ontario and Alberta, generating approximately CAD 90 million in annual revenue.

The business is operating at a profit, with an EBITDA of CAD 3.2 million and a net debt of CAD 2.3 million. Management sees physician hours, technology, and acquisitions as key growth drivers, and is open to using more leverage for strategic acquisitions. NeuPath currently employs about 200,000 patient visits annually and aims to expand its presence across Canada.

The company's main focus is to increase available physician hours, as this is the primary constraint on growth. NeuPath has added six physicians recently and is recruiting from Canada, the U.S., and Europe, with a dedicated recruiter for each region. The company also has approved Labour Market Impact Assessment for six physician spots, with potential for expansion to 12.

NeuPath's physicians often work three days a week, allowing them to maintain broader medical practice ties. The company recently launched a pediatric pain care program for patients aged 14 and above and is expanding into sports medicine. NeuPath is also exploring an emergency room pilot program in the Greater Toronto Area, with the goal of admitting chronic pain patients within one to two days.

The company's strategic initiatives include technology adoption, specifically AI scribing, which has allowed 15 to 20 percent of physicians to treat 3 to 5 more patients per day. Management believes this tool improves patient attention and reduces charting work for doctors. NeuPath's market capitalization is approximately CAD 30 million as of mid-September.